TABLE 1.
Subject disposition and demographics
| Characteristic | No. (%) of subjects in treatment group
|
Value for all subjects | |
|---|---|---|---|
| RFB (300 mg QD) | RFB (150 mg QOD) + FPV-RTV (700/100 mg BID) | ||
| Dosed | 17 | 22 | |
| Completed treatment | 17 | 15 | |
| Withdrawn (total) | 0 | 7 (32) | |
| Withdrawn due to AEs | 0 | 5 (23)a | |
| Withdrawn for other reasons | 0 | 2 (9) | |
| Demographics | |||
| Total | 22 | ||
| Females:males | 4:18 | ||
| Mean age, yr (SD) | 35.3 (9.5) | ||
| Mean wt, kg (SD) | 82.4 (12.4) | ||
| Race, Caucasian:African American | 18:4 | ||
a
Three subjects withdrew for rash, one for nausea, and one for myalgia/fever/increased white blood cell count.